Skip to content

NUTEX HEALTH INC.: 10-Q filed 2011-11-10

What NUTEX HEALTH INC. reported in its quarterly report filed 2011-11-10 (fiscal Q3 2011): 19 published measures, 50 facts as tagged in accession 0001211524-11-000271.

This filing

Form
10-Q (quarterly report)
Filed
2011-11-10
Fiscal period
fiscal Q3 2011
Accession
0001211524-11-000271 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NUTEX HEALTH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-09-302,012,184USD
At 2010-12-312,336,788USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-09-301,755,798USD
At 2010-12-311,985,171USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-153,473USD92
2011-01-01 to 2011-09-30-230,188USD273
2010-07-01 to 2010-09-3012,644USD92
2010-01-01 to 2010-09-30373,668USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-543,138USD273
2010-01-01 to 2010-09-30-1,253,253USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-09-30381,096USD273
2010-01-01 to 2010-09-301,296,264USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-09-30-671,246USD
At 2010-12-31-441,058USD

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2011-07-01 to 2011-09-300USD/shares92
2011-01-01 to 2011-09-30-0.01USD/shares273
2010-07-01 to 2010-09-300USD/shares92
2010-01-01 to 2010-09-300.01USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-77,789USD92
2011-01-01 to 2011-09-30-192,649USD273
2010-07-01 to 2010-09-30-116,984USD92
2010-01-01 to 2010-09-30-346,049USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-09-3020,042USD
At 2010-12-315,087USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-09-301,878,616USD
At 2010-12-312,218,175USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-09-30256,386USD
At 2010-12-31351,617USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2011-09-30111,026USD
At 2010-12-31111,026USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-09-30-131,682USD
At 2010-09-30-69,446USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-07-01 to 2011-09-30219,202USD92
2011-01-01 to 2011-09-30756,733USD273
2010-07-01 to 2010-09-30132,956USD92
2010-01-01 to 2010-09-30402,290USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2011-07-01 to 2011-09-30191,056USD92
2011-01-01 to 2011-09-30542,869USD273
2010-07-01 to 2010-09-3099,387USD92
2010-01-01 to 2010-09-30243,712USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-09-3023,954,056shares
At 2010-12-3123,954,056shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-09-302,403,090USD
At 2010-12-312,402,275USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30458,574USD92
2011-01-01 to 2011-09-301,361,635USD273
2010-07-01 to 2010-09-30448,881USD92
2010-01-01 to 2010-09-301,307,621USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-09-304,436USD273
2010-01-01 to 2010-09-30894USD273

Inspect the source

Entity
NUTEX HEALTH INC. / CIK 0001479681
Captured
2026-09-20T09:08:51.281Z
SEC response SHA-256
1e4c4278b3e624c66aafe376ea707c33deb0bbd1075a4c39e2ccf48ef8d47252

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001479681.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))